Longevity & Wellness

Biological Age Tests, Explained: What Each One Actually Measures

"Biological age test" isn't one product. It's a category name for five genuinely different measurements, and two of them can hand the same person two different numbers in the same week. Here's what each one is actually looking at, why they disagree, and how to pick the one that answers your specific question.

What people mean by "biological age test"

Your chronological age is the easiest number about you to verify: it's on your driver's license. Your biological age is an estimate of how worn, or how well-preserved, your cells and tissues are for that chronological age. Cleveland Clinic frames it as an accumulation of cellular damage over time, shaped by genetics, habits, and environment as much as by the calendar.

The problem is that "biological age test" gets used as if it names a single product, the way "blood pressure test" does. It doesn't. Search for it and you'll land on DNA methylation kits, telomere-length kits, blood-biomarker calculators, glycan panels, and cellular-energy panels, all marketed under the same phrase, all producing a number that looks like an age. A 2024 literature review of biological age measurement methods in Frontiers in Aging notes there is still no scientific consensus on which method measures biological age best, and that different methods can produce different results for the same person.

That's not a knock on the category. Each method is measuring something real. It's a reason to stop asking "which biological age test is the most accurate" and start asking "which biological process am I actually trying to check."

It also helps to know why researchers wanted a biological age number in the first place. Chronological age is a poor predictor of who develops chronic disease and who doesn't; two 70-year-olds can have wildly different risk profiles. Public health researchers wanted a metric that tracked healthspan, the portion of life spent in good function, rather than just lifespan, the number of years survived. That's why every method below is graded against disease and mortality outcomes rather than against a birth certificate. A test that predicts your birth year well isn't automatically useful. A test that predicts your future health is.

The five ways scientists measure biological age

The modern field traces back to 2013, when researcher Steve Horvath published the first widely used epigenetic clock built from DNA methylation patterns. NIA-funded researchers, including Yale's Morgan Levine, later applied machine learning to large longitudinal health datasets to identify biomarker combinations that predicted disease risk and mortality better than chronological age alone, work that eventually produced the composite biomarker scores described below. Nearly every consumer test on the market today is a variation of one of five approaches that grew out of this research line. They use different raw materials, different math, and they're built to answer different questions.

Method What it actually measures Sample Best suited for
Epigenetic (DNA methylation) clocks
Horvath, PhenoAge, GrimAge, DunedinPACE
Chemical "methyl tag" patterns on your DNA that shift in predictable ways with age Blood or saliva Research-grade curiosity about disease and mortality risk
Telomere length Length of the protective caps on the ends of your chromosomes Blood A rough, low-cost proxy for cellular replicative history
Clinical biomarker composite scores
PhenoAge algorithm, Klemera-Doubal (KDM)
Standard labs, e.g. glucose, CRP, albumin, creatinine, run through a published aging algorithm Standard blood draw An affordable score built from labs you can also hand to your doctor
Glycan / immune age Sugar-molecule (glycosylation) patterns attached to your antibodies Blood A narrower look at immune system aging specifically
NAD+ / cellular energy panels Direct levels of NAD⁺, NADH, and total NAD in your blood Finger-prick blood spot Tracking cellular energy status and whether a supplement or protocol is moving the number

Notice the last row doesn't produce an "age" at all. NAD⁺ testing hands you a biomarker reading, not a composite score dressed up as a birthday. That distinction matters enough that it gets its own section below.

Why this matters for your wallet, not just your biology: a full epigenetic clock panel and a single-biomarker panel can be built from the same finger-prick logistics but represent very different amounts of underlying lab work. Sequencing and analyzing hundreds of thousands of methylation sites costs more than running a handful of standard clinical labs or quantifying one molecule directly, and that cost difference shows up in retail price. Composite biomarker panels and single-analyte panels like NAD+ are typically far cheaper to retest quarterly than full DNAm clock panels, which matters if your goal is tracking a trend rather than paying for one impressive-sounding number a single time.

Why two biological age tests can disagree by a decade

This is the part most product pages skip. Even among tests in the same family, agreement is looser than the marketing implies. A 2025 study in The Journals of Gerontology compared four biological aging metrics across five international cohorts and found the measures correlated only weakly with each other, hitting a correlation above 0.5 in just six of twenty-one comparisons. These weren't fringe methods. They were established, published algorithms, run on the same people, using largely the same lab inputs, and they still didn't agree with each other most of the time.

Cross-family comparisons are looser still. A comparative study of telomere length against five separate epigenetic clocks found telomere length correlated only modestly with any of the DNA methylation clocks, while the clocks correlated much more strongly with each other. Telomere length and an epigenetic clock are both called "biological age," but they're tracking different biology and drifting apart the more you compare them.

That divergence shows up in outcomes, too. A 2025 National Institute on Aging-funded analysis of three U.S. cohorts found epigenetic clocks, particularly GrimAge, were consistently stronger predictors of mortality than telomere length, meaning the two methods aren't just numerically different, they carry different amounts of real-world predictive weight. Reporting on the same question, NPR spoke with longevity researchers who cautioned it's genuinely unclear whether different direct-to-consumer biological age tests would return the same result for the same person, since most haven't been cross-validated against each other.

Put concretely: imagine a 50-year-old who orders a telomere test and an epigenetic clock in the same month. The telomere result might land close to their chronological age, while the epigenetic clock reads five years younger, because the two tests are built on different biology, different reference cohorts, and different underlying math, not because one of them is "wrong" and the other is "right." Without knowing which method produced a number, the number by itself isn't very informative.

Part of the disagreement traces back to how each algorithm was built rather than to a flaw in the underlying biology. Epigenetic clocks and biomarker composites are trained on specific reference populations, and the same 2025 cohort analysis found the strength of association between GrimAge and mortality varied meaningfully by sex, with clock scores that incorporate sex differently potentially reading faster or slower biological aging depending on the reference data each algorithm was calibrated against. A clock trained primarily on one population won't necessarily generalize its scoring the same way to everyone who takes it, which is a limitation of the calibration data, not evidence that the underlying molecular changes aren't real.

None of this means the tests are bad. It means a "biological age" number only means something in the context of the specific method that produced it, and comparing your GrimAge result to your friend's telomere-length result is comparing two different rulers.

Which test actually answers your question

Instead of shopping for "the best" biological age test, work backward from what you actually want to know.

"Am I statistically aging faster or slower than my peers?"

This is the epigenetic clock's home turf. It's the method with the deepest published research base tying it to mortality and disease outcomes, and it's the one used in most academic longevity studies. It's also the priciest and the least actionable on its own: it gives you a number, not a next step, and its DNA-methylation snapshot doesn't move much on a monthly timescale.

"I want something affordable I can also bring to my doctor."

Clinical biomarker composite scores use labs you may already have on file, run through a published aging formula. They're the closest thing to a "regular checkup, scored differently" and tend to be the cheapest way to get a repeatable, physician-legible number.

"I'm taking NMN, NR, or getting NAD+ IVs, and I want to know if it's working."

None of the above actually answer this. Epigenetic clocks and biomarker composites aren't built to detect short-term changes from a specific supplement protocol. A direct NAD⁺/NADH panel is, because it measures the exact molecule your protocol is trying to move, and it can be retested on a timeline that matches how fast that molecule actually changes.

"I want to track something over time without spending a fortune."

Favor whichever method has the best cost-per-retest for your goal, not the method with the flashiest single reading. A composite biomarker panel or a single-analyte panel like NAD+ is generally more retest-friendly than a full DNAm clock, simply because the lab work and price point support quarterly or even monthly repeats.

"I just want a free, directional gut check before I spend any money."

This is a reasonable first step, and it's worth being clear-eyed about what it can and can't tell you. Free online biological age calculators, built from self-reported lifestyle questionnaires rather than lab results, can give a rough directional sense of where habits like sleep, exercise, and smoking status are pulling your risk profile. They aren't a substitute for a lab-based test of any kind, but they cost nothing and can help you decide whether a paid test is worth it before you commit to one.

What to do with the number once you have it

A single biological age reading, from any method, is a snapshot with a fairly wide margin of interpretation. Speaking to NPR about how to use these results responsibly, a longevity researcher at Northwestern University described combining several different measurements, including biomarker and imaging-based scores, to build a more integrative picture, rather than relying on any single test in isolation. That's the right instinct for a consumer test, too.

  • Treat it as a baseline, not a verdict. One reading tells you almost nothing about your trajectory. Two or three readings, spaced out consistently, tell you whether you're moving in a direction.
  • Match your retest cadence to the biology being measured. A NAD+ panel can meaningfully shift within 4 to 8 weeks of a supplement change. A DNA methylation clock is designed to reflect slower, longer-run patterns, so retesting it monthly won't show you much signal.
  • Keep the collection conditions consistent. Time of day, fasting state, recent exercise, and hydration can all nudge blood-based results. Testing under similar conditions each time makes trend comparisons more meaningful than the absolute number.
  • Bring it to your doctor, don't diagnose from it. These are screening and educational tools. They're not built to replace a clinical workup, and a concerning result is a reason to have a conversation, not a reason to self-treat.

It's also worth planning your reaction before the result arrives. A single unfavorable reading, on any of these tests, is well within the range of normal measurement variability and shouldn't be treated as a verdict on your health. The useful signal almost always shows up in the trend across two or three tests, not in whether the first number was higher or lower than you hoped.

 

Where NAD+ testing fits, and where it doesn't

NAD⁺ (nicotinamide adenine dinucleotide) is worth calling out on its own, because it gets marketed alongside "biological age tests" constantly, and it deserves an honest placement rather than an inflated one: an NAD⁺ panel is not an epigenetic clock, and it doesn't produce an "age" the way a DNAm test does.

What it does measure is real and well-documented. NAD⁺ is a coenzyme your cells depend on for energy production and DNA repair, and multiple lines of research show it declining with age through direct measurement, not just correlation. Using non-invasive brain imaging, researchers publishing in PNAS measured age-dependent declines in NAD⁺, total NAD, and the NAD⁺/NADH ratio directly in healthy human brains. Blood-based research tells a similar story: a large observational study of whole blood NAD⁺ levels across more than 1,500 adults found a measurable age-related decline, particularly in men in their 40s and beyond. That decline is one of the mechanistic threads tying into the "cellular energy and repair" side of the aging picture that several of the composite and epigenetic frameworks are also, from a different angle, trying to capture.

The mechanism is why researchers pay attention to NAD⁺ specifically. A widely cited 2015 review in Science described NAD⁺ as a required cosubstrate for sirtuins and PARP enzymes, both of which are directly involved in DNA repair and the cellular stress response, and noted that cellular NAD⁺ concentrations shift with age in ways that affect these repair pathways. That's a different kind of evidence than an epigenetic clock's statistical correlation with mortality. It's a proposed mechanism: less available NAD⁺ means less capacity for the repair processes those enzymes carry out, which is part of why NAD-support supplementation became a research target in the first place.

Where NAD⁺ testing earns its keep is verification, not diagnosis. If you're taking nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), or getting NAD⁺ IV infusions, the honest question isn't "what's my biological age," it's "is this actually raising my NAD⁺ levels." A randomized, placebo-controlled trial published in Nature Communications found that chronic nicotinamide riboside supplementation was well tolerated and measurably elevated the NAD⁺ metabolome in healthy middle-aged and older adults, which is exactly the kind of before-and-after change a direct NAD⁺ panel is built to catch, and an epigenetic clock is not.

Boomerang Kits doesn't sell a DNA methylation clock, and this guide isn't going to pretend otherwise. What we do run is the NAD Longevity Blueprint, a CLIA-certified, at-home finger-prick test measuring NAD⁺, NADH, and total NAD directly, with results in the Boomerang app in 24 to 48 hours. If your question is specifically about cellular energy status, whether an NMN or NR protocol is doing anything measurable, or building a baseline you can retest every few months, that's the layer of the biological age picture it's built to answer, honestly labeled as that layer and not as a full-body age score. If your goal is a broader biomarker snapshot instead, our full panel lineup covers hormones, thyroid, and general health markers that feed into the composite-score side of the picture described above.

Frequently asked questions

How accurate is a biological age test?

It depends entirely on the method and what you're measuring accuracy against. Epigenetic clocks have the strongest published ties to mortality and disease outcomes, but even the leading clocks correlate only moderately with each other, and composite biomarker scores from different research groups can diverge on the same dataset. No single method has been established as the definitive gold standard, so "accurate" should be read as "accurate for the specific process this test tracks," not "accurate as a universal age." A test can be scientifically well-validated for predicting group-level health outcomes and still have a fairly wide margin of error for any one individual's exact number.

How do I test my biological age?

Start with what you're trying to learn. For a research-grade estimate of mortality-linked aging, an epigenetic (DNA methylation) clock is the deepest-studied option. For an affordable, doctor-shareable score, a clinical biomarker composite panel works from labs you likely already get. For tracking cellular energy status or checking whether an NAD-support protocol is working, a direct NAD⁺/NADH panel answers that specific question more directly than either of the others.

What slows biological aging the most?

Across the epigenetic-clock research, the most consistently supported levers aren't exotic: regular exercise, sufficient sleep, not smoking, a diet built around whole foods and vegetables, and maintaining a healthy body weight. These same factors show up repeatedly across telomere, biomarker, and DNAm-clock studies, which is itself a useful data point: whatever underlying biology these different tests are each partially capturing, it responds to the same basic inputs.

How often should I retest?

Match the interval to the biology. NAD⁺ and other single-biomarker panels can show meaningful movement in 4 to 8 weeks, so retesting on that cadence makes sense if you're actively adjusting a supplement or lifestyle protocol. Composite biomarker scores are typically retested every 3 to 6 months, often alongside a regular checkup. Epigenetic clocks change slowly and are usually retested annually at most, since more frequent testing rarely reveals new information given the method's longer-run design. Testing more often than the underlying biology actually changes mostly adds cost, not insight.

Is NAD+ testing the same thing as a biological age test?

No, and it's worth being precise about this. NAD⁺ testing measures a specific coenzyme tied to cellular energy production and DNA repair, and reports it as a biomarker level, not a composite "age" score. It's a genuine piece of the broader biological aging picture, and a useful way to verify whether NAD-support supplementation is doing anything measurable, but it isn't a substitute for an epigenetic clock or a full biomarker composite if what you specifically want is an age-equivalent number.